VEGFA and cardiomyopathy: Given the role of VEGF in the survival and proliferation of endothelial and vascular smooth muscle cells, adverse cardiovascular effects have been noted acutely with the use of VEGF inhibitors, including hypertension, thrombosis, and cardiomyopathy [12].